Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily tigecycline versus ertapenem for diabetic foot infections
2006-002257-76Phase 3Completed
- Sponsor
- Wyeth
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot infection (DFI) and type 2 diabetes mellitus (T2DM) comparing Tigecycline arm with Ertapenem arm (2 arms). Primary endpoints: Clinical response rate at test-of-cure (CE population) and Clinical response rate at test-of-cure (c-mITT population). Started Oct 2006; status: completed.
02
Drugs
tigecyclineertapenem
03
Conditions
diabetic foot infection (DFI)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002257-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002257-76.